\-\ Texto\\:\\ \ \(0\)\
\-\ audio\\:\\ asymmetric\\ right\\ snhl\\.\ \(0\)\
\-\ surgical\\ removal\\.\ \(8\)\
\-\ right\\ intracanalicular\\ isointense\\ t1\\,\\ enhancing\\ mass\\.\ \(0\)\
\-\ vestibular\\ schwannoma\ \(8\)\
\-\ for\\ this\\ lesion\\,\\ which\\ is\\ intracanalicular\\,\\ the\\ differential\\ is\\ very\\ limited\\.\ \(0\)\
\-\ 1\\.\\ vestibular\\ \\(\\'acoustic\\'\\)\\ schwannoma\\ \\(intracanalicular\\)\ \(0\)\
\-\ \\*2\\.\\ post\\-op\\ changes\\ could\\ look\\ similar\\,\\ however\\,\\ pt\\ had\\ no\\ prior\\ surgical\\ history\\.\ \(0\)\
\-\ \\*3\\.\\ meningioma\\ is\\ the\\ 2nd\\ most\\ common\\ cpa\\ mass\\.\\ \\ however\\,\\ this\\ is\\ in\\ the\\ differential\\ for\\ a\\ larger\\ \\(ie\\.\\ not\\ completely\\ intracanalicular\\)\\ acoustic\\ schwannoma\\.\ \(0\)\
\-\ 57\\ y\\/o\\ male\\ with\\ asymmetric\\ right\\ snhl\\.\ \(0\)\
\-\ the\\ intracanalicular\\ location\\ of\\ this\\ mass\\ limits\\ the\\ differential\\ in\\ a\\ patient\\ who\\ presents\\ with\\ typical\\ symptoms\\.\ \(0\)\
\-\ diffential\\ diagnosis\\ for\\ cpa\\ cistern\\ masses\\:\ \(0\)\
\-\ 1\\.\\ acoustic\\ schwannoma\\ \\(75\\%\\)\ \(0\)\
\-\ 2\\.\\ meningioma\ \(0\)\
\-\ 3\\.\\ epidermoid\ \(0\)\
\-\ 4\\.\\ other\\ schwannoma\\ \\(cn\\ v\\-\\ next\\ most\\ common\\ cn\\ schwannoma\\)\ \(0\)\
\-\ 5\\.\\ vertebrobasilar\\ ectasia\\/aneurysm\ \(0\)\
\-\ 6\\.\\ neuritis\\ \\(bell\\'s\\)\ \(0\)\
\-\ 7\\.\\ mets\\,\\ lymphoma\\,\\ sarcoid\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ intracanalicular\\:\\ 0\\.20426832859969993\ \(0\)\
\-\ schwannoma\\:\\ 0\\.14455050141594245\ \(0\)\
\-\ snhl\\:\\ 0\\.08671307351528941\ \(0\)\
\-\ cpa\\:\\ 0\\.0738556182704973\ \(0\)\
\-\ vestibular\\:\\ 0\\.06053698047578212\ \(0\)\
\-\ acoustic\\:\\ 0\\.05913786090409072\ \(0\)\
\-\ \\*\\:\\ 0\\.05870463473358122\ \(0\)\
\-\ cn\\:\\ 0\\.05674087307148631\ \(0\)\
\-\ audio\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ ectasia\\/aneurysm\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ asymmetric\\:\\ 0\\.05126023864017816\ \(0\)\
\-\ differential\\:\\ 0\\.050239996839869065\ \(0\)\
\-\ diffential\\:\\ 0\\.04763522305739746\ \(0\)\
\-\ v\\-\\:\\ 0\\.04763522305739746\ \(0\)\
\-\ \\'acoustic\\:\\ 0\\.04585940779534943\ \(0\)\
\-\ vertebrobasilar\\:\\ 0\\.044481978466249364\ \(0\)\
\-\ meningioma\\:\\ 0\\.04056900415376635\ \(0\)\
\-\ bell\\:\\ 0\\.04020329216649662\ \(0\)\
\-\ 3\\.\\:\\ 0\\.03609721249556453\ \(0\)\
\-\ ie\\:\\ 0\\.03430507337003096\ \(0\)\
\-\ 2\\.\\:\\ 0\\.03354869310864516\ \(0\)\
\-\ neuritis\\:\\ 0\\.03342173482903915\ \(0\)\
\-\ 1\\.\\:\\ 0\\.03295295267034075\ \(0\)\
\-\ post\\-op\\:\\ 0\\.030918863791334433\ \(0\)\
\-\ mets\\:\\ 0\\.030393198307752292\ \(0\)\
\-\ however\\:\\ 0\\.029374914266630497\ \(0\)\
\-\ look\\:\\ 0\\.02935231736679061\ \(0\)\
\-\ 57\\:\\ 0\\.02874466259633843\ \(0\)\
\-\ cistern\\:\\ 0\\.0281915011229453\ \(0\)\
\-\ 7\\.\\:\\ 0\\.02810394164768631\ \(0\)\
\-\ common\\:\\ 0\\.027608237184646875\ \(0\)\
\-\ sarcoid\\:\\ 0\\.02706605941434064\ \(0\)\
\-\ 75\\:\\ 0\\.026993007206643094\ \(0\)\
\-\ \\'\\:\\ 0\\.026778898824001796\ \(0\)\
\-\ next\\:\\ 0\\.026778898824001796\ \(0\)\
\-\ \\(\\:\\ 0\\.02675413800903187\ \(0\)\
\-\ \\)\\:\\ 0\\.02642732193012241\ \(0\)\
\-\ 2nd\\:\\ 0\\.026306429212135538\ \(0\)\
\-\ isointense\\:\\ 0\\.025928382142748386\ \(0\)\
\-\ 6\\.\\:\\ 0\\.02563011932008908\ \(0\)\
\-\ larger\\:\\ 0\\.025401469494901737\ \(0\)\
\-\ completely\\:\\ 0\\.025345606312680027\ \(0\)\
\-\ epidermoid\\:\\ 0\\.025127075898785482\ \(0\)\
\-\ most\\:\\ 0\\.02435598940405032\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0227507389447125\ \(0\)\
\-\ limited\\:\\ 0\\.022259458463735043\ \(0\)\
\-\ surgical\\:\\ 0\\.022175577410511772\ \(0\)\
\-\ mass\\:\\ 0\\.02200853716569564\ \(0\)\
\-\ limits\\:\\ 0\\.02174205925458028\ \(0\)\
\-\ typical\\:\\ 0\\.021150905519444426\ \(0\)\
\-\ removal\\:\\ 0\\.02079494476728511\ \(0\)\
\-\ 4\\.\\:\\ 0\\.020768394879017268\ \(0\)\
\-\ similar\\:\\ 0\\.020689423573709186\ \(0\)\
\-\ pt\\:\\ 0\\.01961212194217748\ \(0\)\
\-\ could\\:\\ 0\\.019460234221176247\ \(0\)\
\-\ very\\:\\ 0\\.01914682480529092\ \(0\)\
\-\ location\\:\\ 0\\.018399430166073413\ \(0\)\
\-\ masses\\:\\ 0\\.017830817271580784\ \(0\)\
\-\ this\\:\\ 0\\.017798837283595055\ \(0\)\
\-\ t1\\:\\ 0\\.0167191082482978\ \(0\)\
\-\ right\\:\\ 0\\.016696883502044752\ \(0\)\
\-\ enhancing\\:\\ 0\\.016542923042498513\ \(0\)\
\-\ changes\\:\\ 0\\.015117580100216422\ \(0\)\
\-\ lymphoma\\:\\ 0\\.015075300212280774\ \(0\)\
\-\ y\\/o\\:\\ 0\\.014608821171726176\ \(0\)\
\-\ \\:\\:\\ 0\\.013954010073958826\ \(0\)\
\-\ is\\:\\ 0\\.013883722923079645\ \(0\)\
\-\ who\\:\\ 0\\.01375289141445495\ \(0\)\
\-\ prior\\:\\ 0\\.013543906001249157\ \(0\)\
\-\ for\\:\\ 0\\.013502002752642872\ \(0\)\
\-\ \\,\\:\\ 0\\.013368398297149994\ \(0\)\
\-\ symptoms\\:\\ 0\\.013146033808013203\ \(0\)\
\-\ \\%\\:\\ 0\\.012304450823123503\ \(0\)\
\-\ other\\:\\ 0\\.01215826264631141\ \(0\)\
\-\ diagnosis\\:\\ 0\\.012112465004817406\ \(0\)\
\-\ \\'s\\:\\ 0\\.011629917397327438\ \(0\)\
\-\ had\\:\\ 0\\.011381789007658693\ \(0\)\
\-\ presents\\:\\ 0\\.010775582071036578\ \(0\)\
\-\ lesion\\:\\ 0\\.0107441680617312\ \(0\)\
\-\ which\\:\\ 0\\.009846571526188572\ \(0\)\
\-\ male\\:\\ 0\\.009538305789428846\ \(0\)\
\-\ not\\:\\ 0\\.00762233747988849\ \(0\)\
\-\ history\\:\\ 0\\.007285274924117798\ \(0\)\
\-\ no\\:\\ 0\\.005311383646319765\ \(0\)\
\-\ patient\\:\\ 0\\.005287604511829555\ \(0\)\
\-\ in\\:\\ 0\\.005202434940003147\ \(0\)\
\-\ a\\:\\ 0\\.004896293849612361\ \(0\)\
\-\ the\\:\\ 0\\.004266953231593389\ \(0\)\
\-\ \\.\\:\\ 0\\.0021913293887250787\ \(0\)\
\-\ with\\:\\ 0\\.0014444960011097499\ \(0\)\
\-\ of\\:\\ 0\\.0007191592641851137\ \(0\)\
